Kidney Cancer Association | Association Partnerships

Latest from Kidney Cancer Association

Expert Insights on the Evolving Treatment Paradigm During Kidney Awareness Month

March 29, 2021

Article

In an interview with Targeted Oncology, Walter M. Stadler, MD, discussed recent updates and changes in the kidney cancer landscape, including treatment with HIF and VEGFR inhibitors.

Immunotherapy Plus TKI Regimens Appear Promising for Patients With Renal Cell Carcinoma

November 19, 2020

Article

In an interview with Targeted Oncology, Chung-Han (Joe) Lee, MD, PhD, discussed the use of different targeted therapy and immunotherapy strategies for the treatment of patients with metastatic kidney cancer.

Lenvatinib Plus Everolimus Induces Responses in Rare RCC Population

November 18, 2020

Article

In an interview with Targeted Oncology, Thomas E. Hutson, DO, PharmD, discussed the difficult-to-treat nccRCC patient population and the promise of lenvatinib plus everolimus, as well as other combination regimens.

Award-Winning Physicians to Present Special Lectures on Advances and Unmet Needs in the Field During IKCS 2020

October 24, 2020

Article

At the International Kidney Cancer Symposium Virtual Event, the 2019 Nobel Laureate and recipients of the Kidney Cancer Association’s Andrew C. Noviak Award and the Pieter de Mulder Memorial Award will give lectures on key topics in the kidney cancer landscape on November 6 and 7.